Initial evaluation of (4S)-4-(3-[18F]fluoropropyl)-l-glutamate (FSPG) PET/CT imaging in patients with head and neck cancer, colorectal cancer, or non-Hodgkin lymphoma

被引:0
|
作者
Sonya Y. Park
Camila Mosci
Meena Kumar
Mirwais Wardak
Norman Koglin
Santiago Bullich
Andre Mueller
Mathias Berndt
Andrew W. Stephens
Frederick T. Chin
Sanjiv S. Gambhir
Erik S. Mittra
机构
[1] The Catholic University of Korea,Department of Radiology, Division of Nuclear Medicine, Seoul St. Mary’s Hospital, College of Medicine
[2] Stanford University School of Medicine,Molecular Imaging Program at Stanford (MIPS), Department of Radiology
[3] Bayer Pharma AG,Department of Bioengineering
[4] Life Molecular Imaging GmbH,Department of Materials Science & Engineering
[5] Stanford University,Bio
[6] Stanford University,X Program
[7] Stanford University,Department of Diagnostic Radiology, Division of Nuclear Medicine & Molecular Imaging
[8] Oregon Health & Science University,undefined
来源
关键词
Glutamate; x; transporter; [; F]FSPG; Positron emission tomography; PET/CT; Head and neck cancer; Colorectal cancer; Lymphoma;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 36 条
  • [1] Initial evaluation of (4S)-4-(3-[18F]fluoropropyl)-l-glutamate (FSPG) PET/CT imaging in patients with head and neck cancer, colorectal cancer, or non-Hodgkin lymphoma
    Park, Sonya Y.
    Mosci, Camila
    Kumar, Meena
    Wardak, Mirwais
    Koglin, Norman
    Bullich, Santiago
    Mueller, Andre
    Berndt, Mathias
    Stephens, Andrew W.
    Chin, Frederick T.
    Gambhir, Sanjiv S.
    Mittra, Erik S.
    EJNMMI RESEARCH, 2020, 10 (01)
  • [2] Clinical Evaluation of (4S)-4-(3-[18F]Fluoropropyl)-L-glutamate (18F-FSPG) for PET/CT Imaging in Patients with Newly Diagnosed and Recurrent Prostate Cancer
    Park, Sonya Youngju
    Na, Sae Jung
    Kumar, Meena
    Mosci, Camila
    Wardak, Mirwais
    Koglin, Norman
    Bullich, Santiago
    Mueller, Andre
    Berndt, Mathias
    Stephens, Andrew W.
    Cho, Yong Mee
    Ahn, Hanjong
    Chae, Sun Young
    Kim, Hye Ok
    Moon, Dae Hyuk
    Gambhir, Sanjiv S.
    Mittra, Erik S.
    CLINICAL CANCER RESEARCH, 2020, 26 (20) : 5380 - 5387
  • [3] Pilot Preclinical and Clinical Evaluation of (4S)-4-(3-[18F]Fluoropropyl)-L-Glutamate (18F-FSPG) for PET/CT Imaging of Intracranial Malignancies
    Mittra, Erik S.
    Koglin, Norman
    Mosci, Camila
    Kumar, Meena
    Hoehne, Aileen
    Keu, Khun Visith
    Iagaru, Andrei H.
    Mueller, Andre
    Berndt, Mathias
    Bullich, Santiago
    Friebe, Matthias
    Schmitt-Willich, Heribert
    Gekeler, Volker
    Fels, Lueder M.
    Bacher-Stier, Claudia
    Moon, Dae Hyuk
    Chin, Frederick T.
    Stephens, Andrew W.
    Dinkelborg, Ludger M.
    Gambhir, Sanjiv S.
    PLOS ONE, 2016, 11 (02):
  • [4] (4S)-4-(3-[18F]fluoropropyl)-L-glutamate uptake correlates with cancer stem cell markers in cancer patients
    Lee, Hyo Sang
    Park, Yangsoon
    Chae, Sun Young
    Choi, Chain-Min
    Kim, Sung-Bae
    Koglin, Norman
    Stephens, Andrew
    Dinkelborg, Ludger
    Moon, Dae Hyuk
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [5] Correlation of (4S)-4-(3-[18F]fluoropropyl)-L-glutamate ([18F]FSPG) uptake by positron emission tomography (PET) with immunohistochemical expression of system xC- and CD44 in cancer patients
    Baek, Sora
    Gong, Gyungyub
    Choi, Chang-Min
    Koglin, Norman
    Schatz, Christoph
    Mueller, Andre
    Bacher-Stier, Claudia
    Fels, Lueder
    Dinkelborg, Ludger
    Moon, Dae Hyuk
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [6] Asymmetric Synthesis and Analysis of Enantiomers of 4-(3-Fluoropropyl)-glutamate for Quality Control of (2S,4S)-4-(3-[18F]Fluoropropyl)-L-glutamate ([18F]FSPG) in Human Clinical Trials
    Hsin, Ling-Wei
    Shih, Kai-Ting
    Yang, Chia-Ying
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2017, 60 : S465 - S465
  • [7] (4S)-4-(3-"F-fluoropropyl) L-Glutamate (FSPG), "F-fluoroestradiol (FES), and "Fflurodeoxyglucose (FDG) PET/CT in Phenotyping Patientswith Hormone Refractory Breast Cancer
    Cheng, Mei-Fang
    Chen Wei-Wu
    Huang, Ya-Yao
    Tien, Yu-Wen
    Liu, Chia-Ju
    Lu, Yen-Shen
    Yen, Rouh-Fang
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [8] Imaging Cancer Metastases in a Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) Rodent Model Using (4S)-4-(3-18F-fluoropropyl)-L-Glutamate (FSPG) by Small-Animal PET/CT: a Preclinical Study
    Cheng, M.
    Huang, Y.
    Hsin, L.
    Shiue, C.
    Chang, Y.
    Yen, R.
    Tien, Y.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S409 - S410
  • [9] Exploratory Clinical Trial of (4S)-4-(3-[18F]fluoropropyl)-L-glutamate for Imaging xC Transporter Using Positron Emission Tomography in Patients with Non-Small Cell Lung or Breast Cancer
    Baek, Sora
    Choi, Chang-Min
    Ahn, Sei Hyun
    Lee, Jong Won
    Gong, Gyungyub
    Ryu, Jin-Sook
    Oh, Seung Jun
    Bacher-Stier, Claudia
    Fels, Lueder
    Koglin, Norman
    Hultsch, Christina
    Schatz, Christoph A.
    Dinkelborg, Ludger M.
    Mittra, Erik S.
    Gambhir, Sanjiv S.
    Moon, Dae Hyuk
    CLINICAL CANCER RESEARCH, 2012, 18 (19) : 5427 - 5437
  • [10] Synthesis and analysis of 4-(3-fluoropropyl)-glutamic acid stereoisomers to determine the stereochemical purity of (4S)-4-(3-[18F]fluoropropyl)-L-glutamic acid ([18F]FSPG) for clinical use
    Shih, Kai-Ting
    Huang, Ya-Yao
    Yang, Chia-Ying
    Cheng, Mei-Fang
    Tien, Yu-Wen
    Shiue, Chyng-Yann
    Yen, Rouh-Fang
    Hsin, Ling-Wei
    PLOS ONE, 2020, 15 (12):